Gatuzosiran
Gatuzosiran, a siRNA, is a 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) synthesis reducer. It is used for the study of fatty liver disease.
Product Specifications
CAS Number
[2409783-34-0]
UNSPSC
12352208
Target
17β-HSD
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[Gatuzosiran]
Molecular Formula
C493H653F11N163O311P43S7
Molecular Weight
15603.70
References & Citations
[1]WHO Drug Information - Vol. 38 , No. 4, 2024
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MPX0894K Each
Magic™ Membrane Protein Human OPN3 (Opsin 3) Expressed in vitro E.coli expression system, Full Length
Ask
View Details 
X1042-01 20 µL
XLF (XRCC4-like Factor, Cernunnos, Nonhomologous End Joining Factor 1, Non-homologous End-joining Factor 1, NHEJ 1, NHEJ1, Protein Cernunnos)
Ask
View Details 
X1042-02 100 µL
XLF (XRCC4-like Factor, Cernunnos, Nonhomologous End Joining Factor 1, Non-homologous End-joining Factor 1, NHEJ 1, NHEJ1, Protein Cernunnos)
Ask
View Details